In this study, we found that the level of anti-DCDC2 autoantibody in serum of patients with ICC is elevated, suggesting that it is a potential biomarker for early diagnosis of ICC. This evidence concerns the gene DCDC2 and intrahepatic cholangiocarcinoma.